Smoking Cessation Clinical Trials 2024

Smoking Cessation Clinical Trials 2024

Smoking Cessation research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in smoking cessation clinical trials today.

Trials for Smoking Patients

Trials for Tobacco Use Disorder Patients

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to smoking cessation

What are the top hospitals conducting smoking cessation research?

When it comes to finding effective methods and treatments for smoking cessation, several hospitals are leading the way in clinical trials. In Houston, Texas, M D Anderson Cancer Center is at the forefront with seven ongoing trials dedicated to helping individuals quit smoking. This renowned institution recognizes the critical link between smoking and cancer, driving their dedication to find innovative solutions that can save lives. Similarly, The University of Texas Health Science Center at Houston is actively conducting four smoking cessation trials. With a focus on improving public health outcomes, this hospital aims to empower individuals to overcome nicotine addiction and reduce associated health risks.

Meanwhile, the University of Texas MD Anderson Cancer Center also plays an instrumental role in combating tobacco dependence through its four active clinical trials. By examining various approaches and interventions tailored specifically for smokers seeking support in quitting, they aim to make significant strides towards achieving long-term success rates.

In Charleston, South carolina's Medical University takes part as well by conducting four ongoing clinical tests targeting smoke cessation; clinicians here recognize not only immediate effects but also potential long-term complications linked with such addictive habits. Lastly, the Fred Hutch/University of Washington Cancer Consortium located in Seattle contributes its expertise through three current smoking cessation trials. As part of their mission focused on cancer prevention and research advancements; these studies aim not only to break nicotine addiction but also address the complex factors surrounding it that contribute to poor health outcomes.

These hospitals' commitment towards understanding addiction dynamics provides hope for those struggling with quitting cigarettes while ensuring a brighter future where healthier communities thrive without the harmful effects of tobacco use.

Which are the best cities for smoking cessation clinical trials?

When it comes to smoking cessation clinical trials, several cities offer opportunities for individuals who are looking to quit smoking and participate in innovative research. Houston, Texas leads the way with 16 active trials investigating treatments like Varenicline, Nicotine Replacement, and Telephone-Based Intervention. Seattle, Washington follows closely behind with 6 ongoing studies focusing on unique interventions tailored towards specific groups such as smokers with HIV. Charleston, South carolina also offers 6 active trials exploring various methods including Enhanced Care and Smoking cessation electronic visit (e-visit). Additionally, Boston, Massachusetts and San Francisco California each have 5 active trials that cover a range of approaches designed to support individuals in their journey towards smoking cessation. These cities serve as important hubs for advancing our understanding of effective strategies for quitting smoking.

Which are the top treatments for smoking cessation being explored in clinical trials?

Clinical trials are constantly pushing the boundaries in finding effective treatments for smoking cessation. Among the top contenders, we have:

  • Varenicline: With 10 active trials and a total of 116 all-time clinical trials, this medication is being extensively explored.
  • Bupropion: Currently involved in 5 ongoing trials and boasting an impressive history of 92 all-time clinical trials.
  • Nicotine replacement therapy (NRT): NRT continues to gain attention with its effectiveness, featuring in 3 active studies and over 200 all-time clinical trials. These treatments offer hope for smokers looking to break free from the grip of addiction.
What are the most recent clinical trials for smoking cessation?

Recent clinical trials offer promising strategies for individuals looking to quit smoking. One such trial explores the use of active repetitive transcranial magnetic stimulation (rTMS) as a potential method for smoking cessation. This innovative approach, currently in Phase 2, aims to stimulate specific regions of the brain associated with addiction and cravings. Additionally, Practice Quitting (PQ) Counseling has shown potential in both Phase 1 and Phase 2 studies as an effective tool for smoking cessation support. Another trial investigates the combination of varenicline medication and counseling sessions in a Phase 3 study, providing further insight into successful quitting methods. These ongoing studies indicate great progress towards improving outcomes for those striving to overcome nicotine addiction and achieve a smoke-free life.

What smoking cessation clinical trials were recently completed?

Several recently completed clinical trials have focused on smoking cessation, aiming to help individuals break free from tobacco addiction. These studies represent important advancements in the field.